Stock Research for BIOS


Featured Broker: Ally Invest

Get the due diligence for another stock.


BIOS Stock Chart & Research Data

The BIOS chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the BIOS chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


BIOS Due diligence Resources & Stock Charts

The BIOS stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View BIOS Detailed Price Forecast - CNN Money CNN View BIOS Detailed Summary - Google Finance
Yahoo View BIOS Detailed Summary - Yahoo! Finance Zacks View BIOS Stock Research & Analysis -

Stock Analysis

TradeIdeas View BIOS Trends & Analysis - Trade-Ideas Barrons View BIOS Major Holders - Barrons
NASDAQ View BIOS Call Transcripts - NASDAQ Seeking View BIOS Breaking News & Analysis - Seeking Alpha
Spotlight View BIOS Annual Report - OTC Report View BIOS OTC Short Report -
TradeKing View BIOS Fundamentals - TradeKing Charts View BIOS SEC Filings - Bar Chart
WSJ View Historical Prices for BIOS - The WSJ Morningstar View Performance/Total Return for BIOS - Morningstar
MarketWatch View the Analyst Estimates for BIOS - MarketWatch CNBC View the Earnings History for BIOS - CNBC
StockMarketWatch View the BIOS Earnings - StockMarketWatch MacroAxis View BIOS Buy or Sell Recommendations - MacroAxis
Bullish View the BIOS Bullish Patterns - American Bulls Short Pains View BIOS Short Pain Metrics -

Social Media Mentions

StockTwits View BIOS Stock Mentions - StockTwits PennyStocks View BIOS Stock Mentions - PennyStockTweets
Twitter View BIOS Stock Mentions - Twitter Invest Hub View BIOS Investment Forum News - Investor Hub
Yahoo View BIOS Stock Mentions - Yahoo! Message Board Seeking Alpha View BIOS Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for BIOS - Insider Cow View Insider Transactions for BIOS - Insider Cow
CNBC View BIOS Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for BIOS - OTC Markets
Yahoo View Insider Transactions for BIOS - Yahoo! Finance NASDAQ View Institutional Holdings for BIOS - NASDAQ

Stock Charts

FinViz View BIOS Stock Insight & Charts - StockCharts View BIOS Investment Charts -
BarChart View BIOS Stock Overview & Charts - BarChart Trading View View BIOS User Generated Charts - Trading View

Latest Financial News for BIOS

Edited Transcript of BIOS earnings conference call or presentation 15-Mar-19 1:00pm GMT
Posted on Wednesday March 20, 2019

Q4 2018 BioScrip Inc Earnings and Definitive Merger Agreement with Option Care Call

BioScrip, Inc. -- Moody's places BioScrip's ratings under review for upgrade following the announced merger with HC Group Holdings
Posted on Monday March 18, 2019

Moody's Investors Service ("Moody's") today placed the ratings of BioScrip, Inc. (BioScrip), including the Caa1 Corporate Family Rating (CFR), under review for upgrade. This follows the announcement that BioScrip will merge with HC Group Holdings III, Inc.(dba Option Care). BioScrip will issue common stock to Option Care in an all-stock deal.

BioScrip's stock extends plunge after merger terms disappoint, but analyst recommends remaining bullish
Posted on Monday March 18, 2019

Shares of BioScrip Inc. tumbled 9.0% toward a 9-month low in midday trade Monday, extending the sharp reversal suffered early in the previous session as investors digested the terms of the company's merger deal with Option Care Enterprises Inc. On Friday, the stock soared as much as 71% in premarket trade, and as much as 8.0% during the regular session, before pulling a sharp U-turn to close down 20.3%. Canaccord Genuity analyst Richard Close said that investors may have to suffer some short-term pain, given the disappointment that BioScrip shareholders will own just 20% of the post-merger company, but he remains bullish given the long-term potential. "The need for scale in health care is increasingly paramount as the provider and payer markets consolidate and reimbursement risk is always present," Close wrote in a research note. "Thus, having scale is a significant advantage as [BioScrip] seeks to negotiate rates and drive sustained operating results." The stock has tumbled 35.5% year to date, while the S&P 500 has climbed 12.7%.

BioScrip (BIOS) Reports Loss in Q4, Both Margins Contract
Posted on Monday March 18, 2019

The combined expertise of BioScrip (BIOS) and OptionCare is expected to drive significant growth for the former.

Stock Market & Investing Books

Enter a stock symbol to view the stock details.